论文部分内容阅读
目的:探究肝功能衰竭的患者在治疗中采用血浆置换的临床疗效,并对治疗后的安全性进行观察分析。方法:选取2015年1月~2016年1月住院治疗的120例肝功能衰竭患者,依据随机数字表法分为对照组和观察组,每组60例,对照组采用综合治疗,观察组在对照组基础上联合血浆置换治疗,对两组的临床疗效及安全性进行比较分析。结果:治疗总有效率比较,观察组(86.67%)好于对照组(56.67%),不良反应发生率比较,观察组(23.33%)低于对照组(50.00%),两组比较具有统计学意义(P<0.05)。结论:肝功能衰竭患者的治疗中,在综合治疗的基础上联合血浆置换治疗疗效显著,对患者的肝功能有较好的保护作用,同时降低不良反应的发生,安全性高,值得在肝功能衰竭患者的治疗中广泛应用。
Objective: To investigate the clinical efficacy of plasma exchange in the treatment of patients with liver failure, and to observe the safety after treatment. Methods: A total of 120 patients with liver failure treated in our hospital from January 2015 to January 2016 were divided into control group and observation group according to the random number table. Each group included 60 cases. The control group was treated with combination therapy. In the control group, Group based on the combination of plasma exchange therapy, the clinical efficacy and safety of the two groups were compared. Results: The total effective rate in the observation group (86.67%) was better than that in the control group (56.67%). The incidence of adverse reactions in the observation group (23.33%) was lower than that in the control group (50.00%), Significance (P <0.05). Conclusions: In the treatment of patients with liver failure, the combined treatment of plasma exchange based on the treatment of significant effect, the patient’s liver function has a good protective effect, while reducing the incidence of adverse reactions, high safety, it is worth in liver function The treatment of patients with failure is widely used.